Il semble qu'il y ait eu une erreur en essayant de charger cette page.
Notre équipe a été informée mais veuillez nous contacter en utilisant le widget support email si le problème persiste.
| Trend | Peers | Company |
|---|---|---|
| Is return on equity increasing? | No | Yes |
| Is net profit margin increasing? | Yes | Yes |
| Is asset turnover increasing? | No | No |
| Is equity multiplier increasing? | No | No |
| Competitors Used |
|---|
| Lupin Limited |
| Alembic Pharmaceuticals Limited |
| Medico Remedies Limited |
| Zydus Lifesciences Limited |
| Glenmark Pharmaceuticals Limited |
| Return on Equity Benchmarks | ||||||||
| Comparable Companies | ||||||||
| 500,257 | 533,573 | 540,937 | 532,321 | 532,296 | GLAXO | |||
| Return On Equity | ||||||||
| Latest Twelve Months | NA | NA | NA | NA | NA | NA | ||
| Fiscal Year - 1 | 3% | 7% | 18% | 11% | -2% | 28% | ||
| Fiscal Year - 2 | -12% | 10% | 14% | 15% | 12% | 18% | ||
| Fiscal Year - 3 | 9% | 28% | 8% | 19% | 15% | 17% | ||
| Fiscal Year - 4 | -3% | 28% | 6% | 11% | 13% | 5% | ||
| Fiscal Year - 5 | 4% | 24% | 6% | 19% | 17% | 21% | ||
| Average | 0% | 19% | 10% | 15% | 11% | 18% | ||
| Median | 3% | 24% | 8% | 15% | 13% | 18% | ||
| Benchmarks | Ticker | |||||||
| Lupin Limited | BSE:500257 | |||||||
| Alembic Pharmaceuticals Limited | BSE:533573 | |||||||
| Medico Remedies Limited | BSE:540937 | |||||||
| Zydus Lifesciences Limited | BSE:532321 | |||||||
| Glenmark Pharmaceuticals Limited | BSE:532296 | |||||||
| Financial Performance | ||||||||
| Comparable Companies | ||||||||
| (in millions) | Aug-69 | Nov-60 | Jan-81 | Jun-57 | May-57 | GLAXO | ||
| Latest Fiscal Year | Mar-24 | Mar-24 | Mar-24 | Mar-24 | Mar-24 | Mar-24 | ||
| LTM Period | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | ||
| Revenues | ||||||||
| Latest Twelve Months | 220,016 | 64,194 | 1,510 | 222,474 | 139,608 | 37,046 | ||
| Fiscal Year | 200,108 | 62,286 | 1,449 | 195,474 | 126,454 | 34,537 | ||
| Fiscal Year - 1 | 166,417 | 56,526 | 1,404 | 172,374 | 116,556 | 32,517 | ||
| Fiscal Year - 2 | 164,055 | 53,058 | 1,210 | 151,099 | 123,049 | 32,780 | ||
| Fiscal Year - 3 | 151,630 | 53,931 | 1,224 | 144,035 | 109,439 | 29,256 | ||
| Fiscal Year - 4 | 153,748 | 46,058 | 886 | 142,531 | 106,573 | 32,244 | ||
| Fiscal Year - 5 | 146,646 | 39,347 | 977 | 131,656 | 98,655 | 31,281 | ||
| Net Income | ||||||||
| Latest Twelve Months | 28,685 | 6,047 | 89 | 45,337 | (2,002) | 8,592 | ||
| Fiscal Year | 19,145 | 6,158 | 83 | 38,365 | (18,990) | 5,900 | ||
| Fiscal Year - 1 | 4,301 | 3,420 | 72 | 19,649 | (1,697) | 6,076 | ||
| Fiscal Year - 2 | (15,280) | 5,209 | 48 | 22,416 | 9,417 | 3,808 | ||
| Fiscal Year - 3 | 12,165 | 11,465 | 26 | 22,016 | 9,700 | 2,873 | ||
| Fiscal Year - 4 | (3,995) | 8,288 | 16 | 11,766 | 7,760 | 932 | ||
| Fiscal Year - 5 | 5,121 | 5,844 | 16 | 18,488 | 9,250 | 4,454 | ||
| Total Assets | ||||||||
| Latest Fiscal Quarter Prior | NA | NA | NA | NA | NA | NA | ||
| Latest Fiscal Quarter | NA | NA | NA | NA | NA | NA | ||
| Fiscal Year | 239,972 | 64,456 | 962 | 292,808 | 143,586 | 35,566 | ||
| Fiscal Year - 1 | 229,559 | 61,828 | 874 | 257,564 | 193,717 | 33,266 | ||
| Fiscal Year - 2 | 218,212 | 71,220 | 774 | 277,954 | 170,833 | 46,333 | ||
| Fiscal Year - 3 | 236,104 | 67,090 | 756 | 238,847 | 156,036 | 31,146 | ||
| Fiscal Year - 4 | 249,839 | 59,891 | 753 | 236,866 | 146,848 | 31,332 | ||
| Fiscal Year - 5 | 279,494 | 47,778 | 763 | 234,831 | 132,956 | 39,113 | ||
| Fiscal Year - 6 | 263,054 | 39,411 | 594 | 180,653 | 125,954 | 39,475 | ||
| Common Equity | ||||||||
| Latest Fiscal Quarter Prior | 132,387 | 44,700 | 476 | 187,328 | 93,271 | 15,396 | ||
| Latest Fiscal Quarter | 156,418 | 48,881 | 555 | 218,246 | 84,457 | 16,727 | ||
| Fiscal Year | 142,903 | 48,182 | 524 | 198,295 | 78,479 | 17,776 | ||
| Fiscal Year - 1 | 124,645 | 43,705 | 438 | 175,158 | 94,739 | 17,413 | ||
| Fiscal Year - 2 | 121,533 | 52,376 | 366 | 169,996 | 90,866 | 26,630 | ||
| Fiscal Year - 3 | 138,031 | 50,670 | 325 | 129,923 | 70,646 | 14,783 | ||
| Fiscal Year - 4 | 125,367 | 32,194 | 299 | 103,757 | 60,705 | 18,206 | ||
| Fiscal Year - 5 | 137,422 | 27,188 | 282 | 103,863 | 56,052 | 21,398 | ||
| Fiscal Year - 6 | 135,771 | 22,201 | 267 | 87,445 | 51,635 | 20,573 | ||